Prognostic indicators in patients presenting with acute cardiogenic pulmonary edema treated with CPAP: it's not the acid that matters, it's back to basics

被引:0
|
作者
Dominik Schlosshan
Mark Elliott
机构
[1] Yorkshire Heart Centre,Department of Cardiology
[2] Leeds General Infirmary,Department of Respiratory Medicine
[3] St James's University Hospital,undefined
来源
Critical Care | / 14卷
关键词
Chronic Obstructive Pulmonary Disease; Continuous Positive Airway Pressure; Brain Natriuretic Peptide; Cardiogenic Shock; Systemic Vascular Resistance;
D O I
暂无
中图分类号
学科分类号
摘要
Several prognostic markers have been identified for patients admitted with acute cardiogenic pulmonary edema. Most of the markers are based on clinical risk scores. Unlike hypercapnic respiratory failure, acidosis is not an adverse predictor in these patients. Hemodynamic variables that assess pathophysiological mechanisms may be more helpful to guide appropriate management.
引用
收藏
相关论文
共 20 条
  • [11] Point-of-care Ultrasonography for the Diagnosis of Acute Cardiogenic Pulmonary Edema in Patients Presenting With Acute Dyspnea: A Systematic Review and Meta-analysis
    Al Deeb, Mohammad
    Barbic, Skye
    Featherstone, Robin
    Dankoff, Jerrald
    Barbic, David
    ACADEMIC EMERGENCY MEDICINE, 2014, 21 (08) : 843 - 852
  • [12] N-terminal pro-brain natriuretic peptide as a prognostic predictor in critical care patients with acute cardiogenic pulmonary edema
    Chuang, Chun-Pin
    Lo, Huey-Ming
    Wu, Chang-Yu
    Jong, Yuh-Shiun
    Ho, Feng-Ming
    ACTA CARDIOLOGICA SINICA, 2007, 23 (01) : 20 - 28
  • [13] High peak PaO2 values associated with adverse outcome in patients treated with noninvasive ventilation for acute cardiogenic pulmonary edema and pneumonia
    Schernthaner, Christiana
    Wernly, Bernhard
    Lichtenauer, Michael
    Franz, Marcus
    Lauten, Alexander
    Schulze, Paul C.
    Kabisch, Bjoern
    Braun, Kristina
    Muessig, Johanna
    Masyuk, Maryna
    Hoppe, Uta C.
    Kelm, Malte
    Jung, Christian
    PANMINERVA MEDICA, 2017, 59 (04) : 290 - +
  • [14] BACK TO THE BASICS: RIGHT VENTRICULAR LONGITUDINAL DIMENSION AND MID RIGHT AND LEFT VENTRICULAR RATIO AS PROGNOSTIC AND DIAGNOSTIC TOOLS IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
    Quintero-Martinez, Juan A.
    Wysokinski, Waldemar E.
    Cordova, Sandra N.
    Alam, Md Mashiul
    Vaibhav, Jain
    Vlazny, Danielle T.
    Houghton, Damon E.
    Casanegra, Ana
    Villarraga, Hector
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1788 - 1788
  • [15] The effects of continuous positive airway pressure on plasma brain natriuretic peptide concentrations in patients presenting with acute cardiogenic pulmonary edema with preserved left ventricular systolic function
    Bellone, Andrea
    Etteri, Massimiliano
    Vettorello, Marco
    Berruti, Vittorio
    Maino, Carlo
    Mariani, Massimo
    Clerici, Dante
    Nessi, Italo
    Gini, Giancarlo
    Natalizi, Anna
    Brunati, Pietro
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2010, 28 (02): : 230 - 234
  • [16] HEMOGLOBIN-S-C DISEASE PRESENTING AS ACUTE PNEUMONITIS WITH PULMONARY ANGIOGRAPHIC FINDINGS IN 2 PATIENTS
    BASHOUR, TT
    LINDSAY, J
    AMERICAN JOURNAL OF MEDICINE, 1975, 58 (04): : 559 - 562
  • [17] Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT
    Kose, Nuri
    Yildirim, Tarik
    Akin, Fatih
    Yildirim, Seda Elcim
    Altun, Ibrahim
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (04) : 502 - 502
  • [18] THE PROGNOSTIC IMPACT OF ACUTE BLEOMYCIN INDUCED PNEUMONITIS (BIP) ON OVERALL SURVIVAL IN PATIENTS WITH HODGKIN'S LYMPHOMA (HL) UNIFORMLY TREATED WITH ADRIAMYCIN, BLEOMYCIN, VINBLASTINE AND DACARBAZINE (ABVD) CHEMOTHERAPY
    Ngeow, J.
    Hee, S. W.
    Quek, R.
    Lim, L. C.
    Tao, M.
    Lim, S. T.
    ANNALS OF ONCOLOGY, 2008, 19 : 236 - 237
  • [19] Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
    Alomari, Mohammad
    Covut, Fahrettin
    Al Momani, Laith
    Chadalavada, Pravallika
    Hitawala, Asif
    Young, Mark F.
    Romero-Marrero, Carlos
    JGH OPEN, 2020, 4 (02): : 132 - 139
  • [20] Prognostic Significance of FOXO3 in Pediatric Acute Myeloid Leukemia (AML) Patients Treated with Bortezomib Addition to Standard Therapy: Results from a Children's Oncology Group Phase 3 Clinical Trial
    van Dijk, Anneke D.
    Ruvolo, Peter P.
    Hoff, Fieke W.
    Qiu, Yihua
    Gamis, Alan S.
    Aplenc, Richard
    Kolb, Anders E.
    Alonzo, Todd A.
    Gerbing, Robert B.
    de Bont, Eveline S.
    Bruggeman, Sophia W. M.
    Horton, Terzah M.
    Kornblau, Steven M.
    BLOOD, 2019, 134